Table 3 Predicted binding affinity between BCRP and flavonols.

From: Inhibition of breast cancer resistance protein by flavonols: in vitro, in vivo, and in silico implications of the interactions

Compound no.

Compound

Binding affinity (kcal/mol)

-

Novobiocin

−10.8

7

3,7-Dihydroxyflavone

−9.1

8

3,7,3’-Trihydroxyflavone

−9.5

27

3,5,7,3’,4’-Pentahydroxyflavone (quercetin)

−9.3

29

3,5,7,4’-Tetrahydroxy-3’-methoxyflavone (isorhamnetin)

−9.8

32

3,5,7,3’,4’-Pentahydroxy-8-methylflavone

−10.4

37

3,4’-Dimethoxyflavone

−9.3

39

3,3’,4’-Trimethoxyflavone

−9.7

43

4’-Hydroxy-3,7,3’-trimethoxyflavone

−9.0

46

3,6,3’,4’-Tetramethoxyflavone

−9.3

48

5,7,3’-Trihydroxy-3,4’-dimethoxyflavone

−9.7

50

5-Hydroxy-3,7,3’,4’-tetramethoxyflavone (retusin)

−9.7

52

6,3’-Dihydroxy-3,5,7,4’-tetramethoxyflavone

−9.2

53

3,5,6,7,4’-Pentamethoxyflavone

−8.7

54

3,5,6,7,3’,4’-Hexamethoxyflavone

−9.2